%0 Journal Article
%T Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis
%A Andrea Malfettone
%A Concetta Saponaro
%A Angelo Paradiso
%A Giovanni Simone
%A Annita Mangia
%J BMC Cancer
%D 2012
%I BioMed Central
%R 10.1186/1471-2407-12-106
%X We investigated traditional prognostic factors and a panel of tumor markers not used in routine diagnosis, such as NHERF1, VEGFR1, HIF-1¦Á and TWIST1, in 187 primary invasive breast cancers by immunohistochemistry, stratifying patients into good and poor prognostic groups by the Nottingham Prognostic Index.Grade 2 subgroup analysis showed that the PVI (p = 0.023) and the loss of membranous NHERF1 (p = 0.028) were adverse prognostic factors. Relevantly, 72% of grade 2 tumors were associated to PVI+/membranous NHERF1- expression phenotype, characterizing an adverse prognosis (p = 0.000). Multivariate logistic regression analysis in the whole series revealed poor prognosis correlated with PVI and MIB1 (p = 0.000 and p = 0.001, respectively). Furthermore, in the whole series of breast cancers we found cytoplasmic NHERF1 expression positively correlated to VEGFR1 (r = 0.382, p = 0.000), and in VEGFR1-overexpressing tumors the oncogenic receptor co-localized with NHERF1 at cytoplasmic level.The PVI+/membranous NHERF1- expression phenotype identifies a category of grade 2 tumors with the worst prognosis, including patient subgroup with a family history of breast cancer. These observations support the idea of the PVI+/membranous NHERF1- expression immunophenotype as a useful marker, which could improve the accuracy of predicting clinical outcome in grade 2 tumors.Breast cancer represents a heterogeneous disease with an intrinsic complexity in cellular-biomolecular profile and in its responsiveness to treatment [1]. The management of early-stage breast cancer is based on clinical and pathological parameters which are able to predict distinct patient outcomes. Traditional determinants proven to be of prognostic importance and used in routine practice include the pathological subtype, TNM staging information, histological grade, proliferative activity, receptor status and human epidermal growth factor receptor 2 (HER2) overexpression.The degree of histological differentiation i
%K NHERF1
%K Peritumoral Vascular Invasion
%K Histological grade
%K Breast cancer
%K VEGFR1
%K Nottingham Prognostic Index
%U http://www.biomedcentral.com/1471-2407/12/106